Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.24.1.1.u2
INCOME TAXES (Tables)
12 Months Ended
Mar. 30, 2024
Income Tax Disclosure [Abstract]  
Schedule of Provision for Income Taxes, Income Before Income Taxes
The provision for income taxes was computed based on the following amounts of income from continuing operations before income taxes:
Year Ended March
(In thousands) 2024 2023 2022
Domestic $ (970,325) $ (885,562) $ 518,386 
Foreign 736,640  928,849  1,004,864 
Income (loss) before income taxes $ (233,685) $ 43,287  $ 1,523,250 
Schedule of Provision for Income Taxes
The provision for income taxes consisted of:
Year Ended March
(In thousands) 2024 2023 2022
Current:
Federal $ 236,135  $ (114,772) $ 231,469 
Foreign 759,679  106,192  196,540 
State 134,483  (13,163) 36,461 
1,130,297  (21,743) 464,470 
Deferred:
Federal and state (316,470) (46,677) (177,381)
Foreign (78,630) (6,877) 19,892 
(395,100) (53,554) (157,489)
Income tax expense (benefit) $ 735,197  $ (75,297) $ 306,981 
Schedule of Differences Between Income Taxes Computed by Applying Statutory Federal Income Tax Rate and Income Tax Expense reported in Consolidated Financial Statements
The differences between income taxes computed by applying the statutory federal income tax rate and income tax expense (benefit) reported in the consolidated financial statements are as follows:
Year Ended March
(In thousands) 2024 2023 2022
Tax at federal statutory rate $ (49,074) $ 9,090  $ 319,882 
State income taxes, net of federal tax benefit (28,867) (17,301) 16,641 
Foreign rate differences 54,941  (38,609) (62,928)
Tax reform —  (94,877) 67,358 
Tax litigation 691,053  —  — 
Goodwill impairment 55,076  74,624  — 
Stock compensation 3,908  2,304  (1,977)
Non-taxable contingent consideration adjustments —  —  (28,090)
Interest on tax receivable 11,972  (11,972) — 
Other (3,812) 1,444  (3,905)
Income tax expense (benefit) $ 735,197  $ (75,297) $ 306,981 
Schedule of Deferred Income Tax Assets and Liabilities
Deferred income tax assets and liabilities consisted of the following:
(In thousands) March 2024 March 2023
Deferred income tax assets:
Inventories $ 88,299  $ 74,395 
Depreciation and capitalized research and development 12,785  — 
Deferred compensation 19,904  24,557 
Stock compensation 26,961  27,589 
Operating lease liabilities 352,821  361,676 
Other employee benefits 3,170  — 
Other accrued expenses 117,689  109,050 
Interest expense limitation carryforward 143,077  3,932 
Capital loss carryforwards 153,789  166,587 
Operating loss and credit carryforwards 557,272  331,167 
Gross deferred income tax assets 1,475,767  1,098,953 
Valuation allowances (436,047) (424,932)
Net deferred income tax assets 1,039,720  674,021 
Deferred income tax liabilities:
Depreciation and capitalized research and development —  26,303 
Intangible assets 120,682  277,473 
Operating lease right-of-use assets 320,896  330,235 
Other employee benefits —  3,707 
Outside basis difference in subsidiaries 216,215  46,690 
Other deferred tax liabilities 2,224  2,042 
Deferred income tax liabilities 660,017  686,450 
Net deferred income tax assets (liabilities) $ 379,703  $ (12,429)
Amounts included in the Consolidated Balance Sheets:
Other assets (Note 11) $ 389,783  $ 95,117 
Other liabilities (Note 16) (10,080) (107,546)
$ 379,703  $ (12,429)
Schedule of Reconciliation of Change in Accrual for Unrecognized Income Tax Benefits
A reconciliation of the change in the accrual for unrecognized income tax benefits is as follows:
(In thousands) Unrecognized
Income Tax
Benefits
Accrued
Interest
and Penalties
Unrecognized
Income Tax
Benefits
Including Interest
and Penalties
Balance, March 2021 $ 223,010  $ 38,141  $ 261,151 
Additions for current year tax positions 28,098  —  28,098 
Additions for prior year tax positions (a)
112,850  32,642  145,492 
Reductions for prior year tax positions (895) (532) (1,427)
Reductions due to statute expirations (5,803) (840) (6,643)
Payments in settlement (21,278) (730) (22,008)
Decrease due to divestiture (506) (340) (846)
Currency translation 186  (43) 143 
Balance, March 2022 335,662  68,298  403,960 
Additions for current year tax positions 22,319  —  22,319 
Additions for prior year tax positions 13,324  20,577  33,901 
Reductions for prior year tax positions (3,747) (951) (4,698)
Reductions due to statute expirations (15,369) (1,699) (17,068)
Payments in settlement (3,847) (1,608) (5,455)
Currency translation (172) (10) (182)
Balance, March 2023 348,170  84,607  432,777 
Additions for current year tax positions 15,982  —  15,982 
Additions for prior year tax positions (b)
165,426  78,133  243,559 
Reductions for prior year tax positions (36,943) (3,809) (40,752)
Reductions due to statute expirations (1,436) (383) (1,819)
Payments in settlement (c)
(210,874) (74,659) (285,533)
Currency translation (11) (4) (15)
Balance, March 2024 $ 280,314  $ 83,885  $ 364,199 
(a)The year ended March 2022 included an increase resulting from updated estimates related to intellectual property transfers completed in a prior period.
(b)The year ended March 2024 includes an increase due to uncertainty in the application of court decisions upheld upon appeal.
(c)The year ended March 2024 includes a settlement with the tax authorities related to intellectual property transfers completed in a prior period.
Schedule of Amounts Included in Consolidated Balance Sheets
(In thousands) March 2024 March 2023
Amounts included in the Consolidated Balance Sheets (a):
Unrecognized income tax benefits, including interest and penalties $ 364,199  $ 432,777 
Less deferred tax benefits 61,368  135,175 
Total unrecognized tax benefits $ 302,831  $ 297,602 
(a)Included in the accrued liabilities and other liabilities line items in the Consolidated Balance Sheets.